HK2 and hepatocellular carcinoma: In an HCC mouse model, HK2 knockdown inhibited glycolysis and thus glucose flux to pyruvate and lactate, and simultaneously increased oxidative phosphorylation, which could be diminished by metformin, contributing to further cell death and the inhibition of tumor growth [39].